These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21149447)

  • 1. Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis.
    Joshi S; Sharma B; Kaur S; Majchrzak B; Ueda T; Fukunaga R; Verma AK; Fish EN; Platanias LC
    J Biol Chem; 2011 Feb; 286(8):6017-26. PubMed ID: 21149447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses.
    Joshi S; Kaur S; Redig AJ; Goldsborough K; David K; Ueda T; Watanabe-Fukunaga R; Baker DP; Fish EN; Fukunaga R; Platanias LC
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12097-102. PubMed ID: 19574459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors.
    Mehrotra S; Sharma B; Joshi S; Kroczynska B; Majchrzak B; Stein BL; McMahon B; Altman JK; Licht JD; Baker DP; Eklund EA; Wickrema A; Verma A; Fish EN; Platanias LC
    J Biol Chem; 2013 Aug; 288(33):23814-22. PubMed ID: 23814052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction.
    Shveygert M; Kaiser C; Bradrick SS; Gromeier M
    Mol Cell Biol; 2010 Nov; 30(21):5160-7. PubMed ID: 20823271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
    Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
    Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
    Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
    J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis.
    Verma A; Deb DK; Sassano A; Uddin S; Varga J; Wickrema A; Platanias LC
    J Biol Chem; 2002 Mar; 277(10):7726-35. PubMed ID: 11773065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.
    Dolniak B; Katsoulidis E; Carayol N; Altman JK; Redig AJ; Tallman MS; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Platanias LC
    J Biol Chem; 2008 May; 283(18):12034-42. PubMed ID: 18299328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First MNKs degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines.
    Ramalingam S; Gediya L; Kwegyir-Afful AK; Ramamurthy VP; Purushottamachar P; Mbatia H; Njar VC
    Oncotarget; 2014 Jan; 5(2):530-43. PubMed ID: 24504069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses.
    Altman JK; Glaser H; Sassano A; Joshi S; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Tallman MS; Platanias LC
    Mol Pharmacol; 2010 Oct; 78(4):778-84. PubMed ID: 20664001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eukaryotic initiation factor 4E is a novel effector of mTORC1 signaling pathway in cross talk with Mnk1.
    Batool A; Majeed ST; Aashaq S; Majeed R; Bhat NN; Andrabi KI
    Mol Cell Biochem; 2020 Feb; 465(1-2):13-26. PubMed ID: 31782083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mnk1 and 2 are dispensable for T cell development and activation but important for the pathogenesis of experimental autoimmune encephalomyelitis.
    Gorentla BK; Krishna S; Shin J; Inoue M; Shinohara ML; Grayson JM; Fukunaga R; Zhong XP
    J Immunol; 2013 Feb; 190(3):1026-37. PubMed ID: 23269249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development.
    Ueda T; Watanabe-Fukunaga R; Fukuyama H; Nagata S; Fukunaga R
    Mol Cell Biol; 2004 Aug; 24(15):6539-49. PubMed ID: 15254222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38α regulates cytokine-induced IFNγ secretion via the Mnk1/eIF4E pathway in Th1 cells.
    Salvador-Bernáldez M; Mateus SB; Del Barco Barrantes I; Arthur SC; Martínez-A C; Nebreda AR; Salvador JM
    Immunol Cell Biol; 2017 Oct; 95(9):814-823. PubMed ID: 28611474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
    Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
    Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of eIF4E phosphorylation reduces cell growth and proliferation in primary central nervous system lymphoma cells.
    Muta D; Makino K; Nakamura H; Yano S; Kudo M; Kuratsu J
    J Neurooncol; 2011 Jan; 101(1):33-9. PubMed ID: 20499137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway.
    Liu Z; Li Y; Lv C; Wang L; Song H
    Biochem Biophys Res Commun; 2016 Sep; 478(2):893-9. PubMed ID: 27520370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo.
    Waskiewicz AJ; Johnson JC; Penn B; Mahalingam M; Kimball SR; Cooper JA
    Mol Cell Biol; 1999 Mar; 19(3):1871-80. PubMed ID: 10022874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy.
    Grzmil M; Seebacher J; Hess D; Behe M; Schibli R; Moncayo G; Frank S; Hemmings BA
    Cell Signal; 2016 Sep; 28(9):1412-1421. PubMed ID: 27289018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells.
    Eckerdt F; Beauchamp E; Bell J; Iqbal A; Su B; Fukunaga R; Lulla RR; Goldman S; Platanias LC
    Oncotarget; 2014 Sep; 5(18):8442-51. PubMed ID: 25193863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.